Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1

FiltersClear all

Status

Completed1

Study type

Expanded access1
Interventional4
Observational1

Phase

Not reported1

Investigator

Ole Vielemeyer1

Department

Medicine1

Condition

Infections1
Multiple Myeloma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Recurrence2
Burkitt Lymphoma1

Intervention type

Drug1

Sponsor type

Industry1

Start date

to

Expanded access×Infections×Clear all

Showing 1–1 of 1 studySort:

CompletedExpanded accessNCT04334070 ↗
Novartis Multiple Patient Program for Lamprene® (Clofazimine) for the Treatment of Non-Tuberculous Mycobacterial (NTM) Infections

Show all 15

Show fewer

COVID-191
Hyperlipoproteinemia Type I1
Leukemia1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Lymphoma1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Mantle-Cell1
Melanoma1
Pulmonary Arterial Hypertension1

Ole VielemeyerPI

Intervention: Drug: Lamprene®/Clofazimine
Dates: Started Mar 2024
Sponsor: Novartis Pharmaceuticals Corporation

Non-Tuberculous Mycobacterial (NTM) Infections